Skip to content
  • People
  • Pipeline
  • Publications
  • News
Menu
  • People
  • Pipeline
  • Publications
  • News
  • People
  • Pipeline
  • Publications
  • News
  • Contact us
Menu
  • People
  • Pipeline
  • Publications
  • News
  • Contact us
Contact

News

Read all about our latest news.
Loading...
Loading...
June 13, 2022

Stratified medicine company Monument Therapeutics announces the start of its first clinical study for MT1980, a novel treatment for neuroinflammation

Read more
June 7, 2022

We are attending the BIO Conference: join us at two exciting sessions

Read more
May 2, 2022

Our CEO Jennifer Barnett is featured in The Guardian in an important article discussing the critical impact of postoperative cognitive dysfunction (POCD)

Read more
1 2 … 6 Next »

Contact Us

We believe that neuroscience will be in the next decade what oncology has been in the last.

Get in touch
MT LOGO WHITE PNG-01
info@monumenttx.com
© Copyright 2023  |  Privacy Policy & Terms of Use